Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 95

1.

Cannabinoid receptor type 2 functional variant influences liver damage in children with non-alcoholic fatty liver disease.

Rossi F, Bellini G, Alisi A, Alterio A, Maione S, Perrone L, Locatelli F, Miraglia del Giudice E, Nobili V.

PLoS One. 2012;7(8):e42259. doi: 10.1371/journal.pone.0042259. Epub 2012 Aug 23.

PMID:
22927922
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

The cannabinoid receptor type 2 Q63R variant increases the risk of celiac disease: implication for a novel molecular biomarker and future therapeutic intervention.

Rossi F, Bellini G, Tolone C, Luongo L, Mancusi S, Papparella A, Sturgeon C, Fasano A, Nobili B, Perrone L, Maione S, del Giudice EM.

Pharmacol Res. 2012 Jul;66(1):88-94. doi: 10.1016/j.phrs.2012.03.011. Epub 2012 Mar 24.

PMID:
22465144
[PubMed - indexed for MEDLINE]
3.

A multi-ethnic study of a PNPLA3 gene variant and its association with disease severity in non-alcoholic fatty liver disease.

Zain SM, Mohamed R, Mahadeva S, Cheah PL, Rampal S, Basu RC, Mohamed Z.

Hum Genet. 2012 Jul;131(7):1145-52. doi: 10.1007/s00439-012-1141-y. Epub 2012 Jan 19.

PMID:
22258181
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

The association of genetic variability in patatin-like phospholipase domain-containing protein 3 (PNPLA3) with histological severity of nonalcoholic fatty liver disease.

Rotman Y, Koh C, Zmuda JM, Kleiner DE, Liang TJ; NASH CRN.

Hepatology. 2010 Sep;52(3):894-903. doi: 10.1002/hep.23759.

PMID:
20684021
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Endocannabinoid receptor CB2 in nonalcoholic fatty liver disease.

Mendez-Sanchez N, Zamora-Valdes D, Pichardo-Bahena R, Barredo-Prieto B, Ponciano-Rodriguez G, Bermejo-Martínez L, Chavez-Tapia NC, Baptista-González HA, Uribe M.

Liver Int. 2007 Mar;27(2):215-9.

PMID:
17311616
[PubMed - indexed for MEDLINE]
6.

Markers of activated inflammatory cells correlate with severity of liver damage in children with nonalcoholic fatty liver disease.

De Vito R, Alisi A, Masotti A, Ceccarelli S, Panera N, Citti A, Salata M, Valenti L, Feldstein AE, Nobili V.

Int J Mol Med. 2012 Jul;30(1):49-56. doi: 10.3892/ijmm.2012.965. Epub 2012 Apr 10.

PMID:
22505182
[PubMed - indexed for MEDLINE]
7.

I148M patatin-like phospholipase domain-containing 3 gene variant and severity of pediatric nonalcoholic fatty liver disease.

Valenti L, Alisi A, Galmozzi E, Bartuli A, Del Menico B, Alterio A, Dongiovanni P, Fargion S, Nobili V.

Hepatology. 2010 Oct;52(4):1274-80. doi: 10.1002/hep.23823.

PMID:
20648474
[PubMed - indexed for MEDLINE]
8.

The I148M PNPLA3 polymorphism influences serum adiponectin in patients with fatty liver and healthy controls.

Valenti L, Rametta R, Ruscica M, Dongiovanni P, Steffani L, Motta BM, Canavesi E, Fracanzani AL, Mozzi E, Roviaro G, Magni P, Fargion S.

BMC Gastroenterol. 2012 Aug 16;12:111.

PMID:
22898488
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Non-alcoholic steatohepatitis in children.

Nanda K.

Pediatr Transplant. 2004 Dec;8(6):613-8. Review.

PMID:
15598336
[PubMed - indexed for MEDLINE]
10.

Evaluation of inflammatory and angiogenic factors in patients with non-alcoholic fatty liver disease.

Coulon S, Francque S, Colle I, Verrijken A, Blomme B, Heindryckx F, De Munter S, Prawitt J, Caron S, Staels B, Van Vlierberghe H, Van Gaal L, Geerts A.

Cytokine. 2012 Aug;59(2):442-9. doi: 10.1016/j.cyto.2012.05.001. Epub 2012 May 31.

PMID:
22658783
[PubMed - indexed for MEDLINE]
11.

The APOC3 T-455C and C-482T promoter region polymorphisms are not associated with the severity of liver damage independently of PNPLA3 I148M genotype in patients with nonalcoholic fatty liver.

Valenti L, Nobili V, Al-Serri A, Rametta R, Leathart JB, Zappa MA, Dongiovanni P, Fracanzani AL, Alterio A, Roviaro G, Daly AK, Fargion S, Day CP.

J Hepatol. 2011 Dec;55(6):1409-14. doi: 10.1016/j.jhep.2011.03.035. Epub 2011 Jul 21.

PMID:
21777557
[PubMed - indexed for MEDLINE]
12.

Role of cannabinoid receptors in alcoholic hepatic injury: steatosis and fibrogenesis are increased in CB2 receptor-deficient mice and decreased in CB1 receptor knockouts.

Trebicka J, Racz I, Siegmund SV, Cara E, Granzow M, Schierwagen R, Klein S, Wojtalla A, Hennenberg M, Huss S, Fischer HP, Heller J, Zimmer A, Sauerbruch T.

Liver Int. 2011 Jul;31(6):860-70. doi: 10.1111/j.1478-3231.2011.02496.x. Epub 2011 Mar 8.

PMID:
21645218
[PubMed - indexed for MEDLINE]
13.

Association between a polymorphism in cannabinoid receptor 2 and severe necroinflammation in patients with chronic hepatitis C.

Coppola N, Zampino R, Bellini G, Macera M, Marrone A, Pisaturo M, Boemio A, Nobili B, Pasquale G, Maione S, Adinolfi LE, Perrone L, Sagnelli E, Miraglia Del Giudice E, Rossi F.

Clin Gastroenterol Hepatol. 2014 Feb;12(2):334-40. doi: 10.1016/j.cgh.2013.05.008. Epub 2013 May 22.

PMID:
23707465
[PubMed - indexed for MEDLINE]
14.

Expression of adiponectin and its receptors in livers of morbidly obese patients with non-alcoholic fatty liver disease.

Ma H, Gomez V, Lu L, Yang X, Wu X, Xiao SY.

J Gastroenterol Hepatol. 2009 Feb;24(2):233-7. doi: 10.1111/j.1440-1746.2008.05548.x. Epub 2008 Aug 17.

PMID:
18713296
[PubMed - indexed for MEDLINE]
15.

Surgical treatment of non-alcoholic steatohepatitis and non-alcoholic fatty liver disease.

Weiner RA.

Dig Dis. 2010;28(1):274-9. doi: 10.1159/000282102. Epub 2010 May 7.

PMID:
20460923
[PubMed - indexed for MEDLINE]
16.

Interleukin-17 exacerbates hepatic steatosis and inflammation in non-alcoholic fatty liver disease.

Tang Y, Bian Z, Zhao L, Liu Y, Liang S, Wang Q, Han X, Peng Y, Chen X, Shen L, Qiu D, Li Z, Ma X.

Clin Exp Immunol. 2011 Nov;166(2):281-90. doi: 10.1111/j.1365-2249.2011.04471.x.

PMID:
21985374
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Genetic polymorphisms of the human PNPLA3 gene are strongly associated with severity of non-alcoholic fatty liver disease in Japanese.

Kawaguchi T, Sumida Y, Umemura A, Matsuo K, Takahashi M, Takamura T, Yasui K, Saibara T, Hashimoto E, Kawanaka M, Watanabe S, Kawata S, Imai Y, Kokubo M, Shima T, Park H, Tanaka H, Tajima K, Yamada R, Matsuda F; Takeshi Okanoue, Japan Study Group of Nonalcoholic Fatty Liver Disease.

PLoS One. 2012;7(6):e38322. doi: 10.1371/journal.pone.0038322. Epub 2012 Jun 14.

PMID:
22719876
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Leptin, free leptin index, insulin resistance and liver fibrosis in children with non-alcoholic fatty liver disease.

Nobili V, Manco M, Ciampalini P, Diciommo V, Devito R, Piemonte F, Comparcola D, Guidi R, Marcellini M.

Eur J Endocrinol. 2006 Nov;155(5):735-43.

PMID:
17062890
[PubMed - indexed for MEDLINE]
Free Article
19.

Cannabinoid CB2 receptor gene (CNR2) polymorphism is associated with chronic childhood immune thrombocytopenia in Egypt.

Mahmoud Gouda H, Mohamed Kamel NR.

Blood Coagul Fibrinolysis. 2013 Apr;24(3):247-51. doi: 10.1097/MBC.0b013e32835aba1d.

PMID:
23406660
[PubMed - indexed for MEDLINE]
20.

LPIN1 rs13412852 polymorphism in pediatric nonalcoholic fatty liver disease.

Valenti L, Motta BM, Alisi A, Sartorelli R, Buonaiuto G, Dongiovanni P, Rametta R, Pelusi S, Fargion S, Nobili V.

J Pediatr Gastroenterol Nutr. 2012 May;54(5):588-93. doi: 10.1097/MPG.0b013e3182442a55.

PMID:
22157924
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk